Leveljump Healthcare Corp. announced a non-brokered private placement of up to 5,000,000 preferred share units at a price of CAD 1 per unit for the aggregate gross proceeds of CAD 5,000,000 on September 14, 2023. Each unit consists of one common share at an issue price of CAD 0.10 and one 12% cumulative redeemable convertible Class A Series 1 preferred share at an issue price of CAD 0.90 and at a conversion price of CAD 0.20 per common share.

Each Preferred Share is non-voting, redeemable and carries a cumulative annual dividend of 12% paid quarterly, along with an annual top-up dividend representing 25% of the portion of LevelJump?s EBITDA that is above CAD 2 million, on a pro-rata basis. All securities issued pursuant to this financing will be subject to resale restrictions for a period of four months and one day from closing under applicable securities legislation. The Company has sold 214,000 units in prior offerings and intends to issue 1,130,000 units as part of the consideration for the Alberta Acquisitions till date.

The balance of the offering will be sold primarily to accredited investors pursuant to exemptions under applicable securities laws.